Drug
Volrustomig
Volrustomig: highest development phase Phase 3, developed by AstraZeneca. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Volrustomig NCT06079671 | Phase 3 | Locally Advanced Cervical Cancer |
| Volrustomig NCT07000149 | Phase 1 | Advanced Clear Cell Renal Cell Carcinoma |
Latest
Follow Volrustomig on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.